Home › Kanser sa Prostate › California › Los Angeles
Pag-aaral pangklinika para sa Kanser sa Prostate sa Los Angeles, CA
Isang pag-aaral para sa Kanser sa Prostate ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Los Angeles. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
High Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe)
Nagre-recruitPhase 2
- Cedars Sinai Medical Center, Los Angeles
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Nagre-recruitPhase 1/2
- Research Site, Los Angeles
Study of AR Suppression With Carotuximab in Metastatic, Castration-Resistant Prostate Canc
Nagre-recruitPhase 2
- Cedars-Sinai Medical Center, Los Angeles
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Nagre-recruitPhase 1
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Nagre-recruitPhase 1/2
- UCLA Jonsson Comprehensive Cancer Center, Los Angeles
- USC Norris Comprehensive Cancer Center, Los Angeles
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Nagre-recruitPhase 3
- Cedars-Sinai Medical Center, Los Angeles
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Nagre-recruitPhase 2
- Keck Medicine of USC Koreatown, Los Angeles
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Completed Focal Therapy for Prostate Cancer.
Nagre-recruitPhase 2
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Nagre-recruitPhase 3
- UCLA Hematology/Oncology - Santa Monica ( Site 0044), Los Angeles
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
Nagre-recruitPhase 1/2
- Research Site, Los Angeles
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Nagre-recruitPhase 3
- Cedars-Sinai Cancer at Cedars-Sinai Medical Center, Los Angeles
- Ronald Reagan UCLA Medical Center - Drug Information Center, Los Angeles
- UCLA Department of Medicine - Hematology/Oncology, Los Angeles
- at 1 pa
A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
Nagre-recruitPhase 1
- START Los Angeles, Los Angeles
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Nagre-recruitPhase 2/3
- VA Greater LA Healthcare System, Los Angeles
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Nagre-recruitPhase 3
- Research Site, Los Angeles
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Nagre-recruitPhase 3
- Cedars-Sinai Medical Center ( Site 0068), Los Angeles
- UCLA Hematology/Oncology - Santa Monica ( Site 0002), Los Angeles
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
Nagre-recruitPhase 3
- Urology Group of Southern California, Los Angeles
- Greater Los Angeles VA Medical Center, Los Angeles
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Nagre-recruitPhase 3
- Cedars-Sinai Medical Center, Los Angeles
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1
- USC/Norris Comprehensive Cancer Center, Los Angeles
Longitudinal Advanced Prostate Cancer Cohort (LAPCC)
Nagre-recruitObservasyonal na pag-aaral
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
MRI-Based Machine Learning Approach Versus Radiologist MRI Reading for the Detection of Prostate Cancer, The PRIMER Trial
Nagre-recruit
- USC / Norris Comprehensive Cancer Center, Los Angeles
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Nagre-recruitPhase 1
- University of Southern California, Los Angeles
- Cedars-Sanai Medical Center - Samuel Oschin Comprehensive Cancer, Los Angeles
- Cedars-Sanai Medical Center, Los Angeles
Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
Nagre-recruitPhase 2
- START Los Angeles, Los Angeles
Prostate Cancer Postoperative Stereotactic Body Radiotherapy With Adaptive Technology for Minimizing Toxicity
Nagre-recruitObservasyonal na pag-aaral
- University of California at Los Angeles, Los Angeles
High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma
Nagre-recruit
- University of California at Los Angeles / Jonsson Comprehensive Cancer Center, Los Angeles
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Nagre-recruitPhase 3
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- University of California, Los Angeles (UCLA), Los Angeles
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Nagre-recruitPhase 2
- VA Greater Los Angeles Healthcare System, Los Angeles
- UCLA Clark Urology Center, Los Angeles
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Nagre-recruitPhase 1
- USC Norris Comprehensive Cancer Center, Los Angeles
- UCLA Department of Medicine, Los Angeles
NLP-Based Feedback to Improve Risk Comms and Informed Shared Decision Making
Nagre-recruit
- Cedars-Sinai Medical Center, Los Angeles
WALNUTS for POWER: Polyphenols, Omega-3 Fatty Acids, Weight Loss, and EneRgy
Nagre-recruitPhase 2
- Cedars-Sinai Medical Center, Los Angeles
A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer
Nagre-recruitPhase 2
- University of California, Los Angeles (Data and Specimen Analysis Only), Los Angeles
PSMA PET Combined With MRI for the Detection of PCa
Nagre-recruitPhase 3Malugod na tinatanggap ang malusog na boluntaryo
- University of California Los Angeles, Los Angeles
99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer
Nagre-recruitMaagang Phase 1
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE Trial
Nagre-recruitPhase 2
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
Nagre-recruitPhase 2
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Nagre-recruitPhase 3
- Kaiser Permanente Los Angeles Medical Center, Los Angeles
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
- at 2 pa
Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification
Nagre-recruitObservasyonal na pag-aaral
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
Nagre-recruitPhase 2
- VA Greater Los Angeles Healthcare System, Los Angeles
Image-Guided Biopsies to Identify Mechanisms of Resistance in Patients With Metastatic Castration Resistant Prostate Cancer Treated With 177Lu-PSMA Radioligand Therapy
Nagre-recruitPhase 1
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
Nagre-recruitPhase 1
- Start Lacn, Los Angeles
Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors
Nagre-recruit
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
Active Surveillance for Cancer of the Prostate (ASCaP)
Nagre-recruitObservasyonal na pag-aaral
- University of California Los Angeles, Los Angeles
Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer
Nagre-recruit
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr
Nagre-recruit
- UCLA, Los Angeles
HIFU for Focal Ablation of Prostate Tissue: An Observational Study
Nagre-recruitObservasyonal na pag-aaral
- University of California, Los Angeles, Los Angeles
Green Tea and Quercetin in Combination With Docetaxel Chemotherapy in Castration-resistant Prostate Cancer Patients
Nagre-recruitPhase 1/2
- Charles R. Drew University of Medicine and Science, Los Angeles
Mechanisms of Resistance to PSMA Radioligand Therapy
Nagre-recruitObservasyonal na pag-aaral
- University of California, Los Angeles, Los Angeles
Access to Genetic Testing in Underserved Patients With Cancer
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- USC / Norris Comprehensive Cancer Center, Los Angeles
Re-treatment With 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer, RE-LuPSMA Trial
Nagre-recruitPhase 2
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Intensive Cholesterol-Lowering and CD8+ T Cells in Prostate Cancer
Nagre-recruitPhase 2
- Cedars-Sinai Medical Center, Los Angeles
Comparing a New PSMA Imaging Agent to MRI for Detecting Prostate Cancer, BEACON Trial
Nagre-recruitMaagang Phase 1
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT)
Nagre-recruitPhase 2
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Nagre-recruitPhase 1
- USC - Norris Comprehensive Cancer Center, Los Angeles
Image-Guidance and Online Adaptation With Stereotactic Body Radiation Therapy for the Treatment of Localized Prostate Cancer, MANTICORE Trial
Nagre-recruit
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Vascular Optimized Radiotherapy Tuned to Critical Structures for Erectile Function Using High-Precision X-Ray Treatment
Nagre-recruitPhase 3
- University of California at Los Angeles, Los Angeles
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
Nagre-recruitPhase 1/2
- University of Southern California, Los Angeles
RCT of NLP-Based Feedback for Improving SDM in Men With Localized Prostate Cancer
Nagre-recruit
- Cedars Sinai Medical Center, Los Angeles
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- Research Site 125, Los Angeles
- Research Site 133, Los Angeles
- Research Site 103, Los Angeles
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Nagre-recruitPhase 3
- Los Angeles County-USC Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
Nagre-recruitPhase 1/2
- University of California, Los Angles (UCLA) Department of Medicine - Hematology/Oncology, Los Angeles
18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer
Nagre-recruitPhase 4
- VA Greater Los Angeles Healthcare System, Los Angeles
Pag-aaral para sa Kanser sa Prostate sa ibang lungsod
- New York City, NY103 pag-aaral
- Houston, TX76 pag-aaral
- Boston, MA59 pag-aaral
- St. Louis, MO46 pag-aaral
- Chicago, IL45 pag-aaral
- San Francisco, CA45 pag-aaral
- Philadelphia, PA44 pag-aaral
- Baltimore, MD43 pag-aaral
- Nashville, TN43 pag-aaral
- Seattle, WA42 pag-aaral
- Washington, DC38 pag-aaral
- Dallas, TX36 pag-aaral
Iba pang pag-aaral sa Los Angeles
- Non-Small Cell Lung Cancer87 pag-aaral
- Kanser (lahat ng uri)74 pag-aaral
- Kanser sa Suso73 pag-aaral
- Colorectal Cancer59 pag-aaral
- Metastatic Cancer57 pag-aaral
- Kanser sa Ovary50 pag-aaral
- Kanser sa Baga45 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg42 pag-aaral
- Kanser sa Pancreas35 pag-aaral
- Kanser ng Endometrium34 pag-aaral
- Melanoma34 pag-aaral
- Triple-Negative Breast Cancer27 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.